TOPRA annual Human Medicines Symposium 2018 Section 1: The Programme and Speakers It will help considerably in the planning and organisation of our events if you would answer the following questions. Thank you very much. Question Title * 1. Which would you consider the most outstanding session for you and why? TOPRA Annual lecture 2018 HMA/EMA Strategy work plan International collaboration Brexit Medicinal products with integral medical devices – bringing two worlds together Developing cooperation at the interface between medicinal products and medical devices HTA – Market Access EU Telematics and SPOR – opportunity for regulatory optimisation for human and veterinary medicinal products The regulatory role in early access schemes to patients ATMPs: cell and gene therapies, the future? Please provide more details on why you found this session outstanding - was it the overall session or an individual contributor? Question Title * 2. Which would you consider the most useful session for you and why? TOPRA Annual lecture 2018 HMA/EMA Strategy work plan International collaboration Brexit Medicinal products with integral medical devices – bringing two worlds together Developing cooperation at the interface between medicinal products and medical devices HTA – Market Access EU Telematics and SPOR – opportunity for regulatory optimisation for human and veterinary medicinal products The regulatory role in early access schemes to patients ATMPs: cell and gene therapies, the future? Please provide more details on why you found this session useful - was it the overall session or an individual contributor? Question Title * 3. Which would you consider the least useful session for you and why? TOPRA Annual lecture 2018 HMA/EMA Strategy work plan International collaboration Brexit Medicinal products with integral medical devices – bringing two worlds together Developing cooperation at the interface between medicinal products and medical devices HTA – Market Access EU Telematics and SPOR – opportunity for regulatory optimisation for human and veterinary medicinal products The regulatory role in early access schemes to patients ATMPs: cell and gene therapies, the future? Please provide more details on why you found this session least useful Question Title * 4. Can we improve on anything? Please detail Question Title * 5. Did you attend any of the parallel sessions ? Yes No Was not aware of parallel sessions Question Title * 6. Did you attend of any of the Professional Competence sessions ? Yes No I was not aware of the Professional Development sessions Which topics did you feel were especially valuable or would you like to see included in the future? Question Title * 7. How useful was the pullout programme in your delegate badge? Very useful Useful Not practical Did not use it Question Title * 8. How would you rate the online programme at www.toprasymposium.org? Very useful Useful Not practical N/A – did not access it Next